Search

ID3021 Acquired resistance to with EGFR tyrosine kinase inhibitors by the EGFR T790M mutation in non-small cell lung cancer

S33 2017-09-05

Van Thanh Ta

Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model

6191-6197 2024-02-29

Nur Fatihah Ronny Sham, Harissa Husainy Hasbullah, Narimah Abdul Hamid Hasani, Nurhaslina Hasan, Suraya Othman, Nora Julianna Osman, Muhammad Khalis Abdul Karim, Syed Baharom Syed Ahmad Fuad, Mohammad Johari Ibahim

**The SDHD H102R Variant is a Genetic Risk Factor for Head and Neck Paraganglioma in the Russian Population**

8451-8457 2026-04-30

Anastasiya Snezhkina, Maria Fedorova, Dmitry Kalinin, Anna Ikonnikova, Marina Emelyanova, Anna Kudryavtseva, Vladislav Pavlov

ID2006 Crosstalk between effector cells of adaptive immunity and mesenchymal stromal cells

S38-S39 2017-09-05

Aleksandra Gornostaeva

CAR-T-Cell Therapy: Present Progress and Future strategies

4920-4929 2022-02-28

Muddasir Hassan Abbasi, Amna Riaz, Muhammad Babar Khawar, Adil Farooq, Ayesha Majid, Nadeem Sheikh

ID:4003 COP9 signalosome in regulating EGFR oncogenic signals

S5 2017-09-05

Mong-Hong Lee, Lekun Fang, Bo Chen, Hyun-Ho Choi, Ji-Hyun Shin, Liem Phan, Sai-Ching Yeung

Search Results